Synedica BPC-157 & TB-500 40mg Injection Pen Kit
Two of the most studied recovery-focused peptides in current research literature — combined in a single Synedica pre-filled pen. Oxford Peptide Innovations stocks this kit directly from Synedica, batch-verified and ready for laboratory use.
Synedica BPC-157 & TB-500 40mg: Two Compounds, One Kit
BPC-157 and TB-500 occupy different but complementary areas of current peptide research. BPC-157 — a pentadecapeptide originally derived from gastric protective proteins — has been studied extensively for its role in angiogenic signalling pathways. TB-500, a synthetic Thymosin Beta-4 fragment, has attracted research interest for its involvement in cell migration and actin regulation.
Combining them in a single pre-filled pen format does two things: it simplifies lab handling and it removes the need to source and reconstitute two separate compounds for studies examining both mechanisms.
Each kit is:
- Manufactured by Synedica to documented purity standards
- Pre-filled at 40mg combined for consistent laboratory use
- Batch-tested and sealed before dispatch
- Supplied with full traceability documentation
- For research and development use only
The Published Research Context
Both compounds have attracted significant attention in preclinical literature:
- PubMed Central – BPC-157 in Musculoskeletal Models
- PubMed – TB-500 Quantification and Wound-Healing Activity
Provided for scientific context only. Not medical advice.
Synedica Reviews — What Matters Beyond the Name
Synedica reviews in research circles consistently return to the same question: is the documentation there? At Oxford Peptide Innovations, every Synedica order includes full batch traceability — the practical answer to that question.
Storage
- Refrigerate at 2–8°C, away from direct light and heat
- Avoid shaking or temperature extremes
- Sterile handling technique required
- Follow standard protocols after first use
Research Use Only
This product is sold strictly for laboratory R&D. Not for human or animal consumption. Not a medicine or supplement. Not MHRA or FDA evaluated for therapeutic use. For qualified researchers in appropriate settings only. Purchasers must be 18+.
Related Products
- Synedica Retatrutide 40mg Pen
- Synedica Tirzepatide 40mg Pen
- Synedica Biotin 40mg Pen
- Alluvi BPC-157 & TB-500 40mg
- Full Peptide Range
FAQ
Is Synedica legit for BPC-157 and TB-500? Yes. Oxford Peptide Innovations stocks verified Synedica products with full batch documentation on every order.
Why combine BPC-157 and TB-500 in one pen? For studies examining both compounds, the combined format reduces prep time and variables. For single-compound research, see our Alluvi individual listings.
Is this suitable for human use? No. R&D use only.













